XOMA Royalty (XOMA) Return on Capital Employed Growth (3y) (2014 - 2026)
XOMA Royalty (XOMA) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,782.00 |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 2,522.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,522.00 |
| Jun 30, 2025 | -1,990.00 |
| Mar 31, 2025 | -2,788.00 |
| Dec 31, 2024 | -3,313.00 |
| Sep 30, 2024 | -3,353.00 |
| Jun 30, 2024 | -2,974.00 |
| Mar 31, 2024 | -2,890.00 |
| Dec 31, 2023 | -3,953.00 |
| Sep 30, 2023 | -379.00 |
| Jun 30, 2023 | -921.00 |
| Mar 31, 2023 | -643.00 |
| Dec 31, 2022 | -803.00 |
| Sep 30, 2022 | 1,782.00 |
| Jun 30, 2022 | 3,122.00 |
| Mar 31, 2022 | 2,975.00 |
| Dec 31, 2021 | 4,714.00 |
| Sep 30, 2021 | 4,929.00 |
| Jun 30, 2021 | -3,776.00 |
| Mar 31, 2021 | -4,906.00 |
| Dec 31, 2020 | -2,936.00 |